Oxaliplatin in combination with 5-fluorouracil/leucovorin or capecitabine in elderly patients with metastatic colorectal cancer.
暂无分享,去创建一个
R. Greil | A. Hinke | A. Grothey | T. Seufferlein | W. Schmiegel | W. Freier | R. Porschen | H. Arkenau | U. Graeven | H. Schmoll | A. Kretzschmar | S. Kubicka | C. Englisch-Fritz
[1] C. Tournigand,et al. FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study , 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] R. Greil,et al. Phase III study of capecitabine plus oxaliplatin compared with fluorouracil and leucovorin plus oxaliplatin in metastatic colorectal cancer: a final report of the AIO Colorectal Study Group. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] C. Tournigand,et al. Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] J. Feliu,et al. XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer , 2006, British Journal of Cancer.
[5] A. Gambardella,et al. Capecitabine plus oxaliplatin for the first‐line treatment of elderly patients with metastatic colorectal carcinoma , 2005, Cancer.
[6] J. Feliu,et al. Capecitabine as first-line treatment for patients older than 70 years with metastatic colorectal cancer: an oncopaz cooperative group study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] T. Conroy,et al. XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] C. Alliot,et al. Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly , 2004, British Journal of Cancer.
[9] S. Lichtman. Chemotherapy in the elderly. , 2004, Seminars in oncology.
[10] A. Shields,et al. Treatment of advanced colorectal carcinoma with oxaliplatin and capecitabine , 2004, Cancer.
[11] E. Van Cutsem,et al. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] E Harrison,et al. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] C. Wilson,et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] Daniel S. Miller,et al. The annual report to the nation on the status of cancer, 1973–1997, with a special section on colorectal cancer , 2000, Cancer.
[15] R. James,et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial , 2000, The Lancet.
[16] M. van Glabbeke,et al. New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.
[17] C. Mulrow,et al. Colorectal cancer screening: clinical guidelines and rationale. , 1997, Gastroenterology.
[18] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[19] Daniel J Sargent,et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] Robert J. Mayer,et al. Erratum: Colorectal cancer screening: Clinical guidelines and rationale (Gastroenterology (1997) 112 (594-642)) , 1997 .
[21] D. Cox. Regression Models and Life-Tables , 1972 .